number of access : ?
number of downloads : ?
ID 116090
Author
Bando, Hiroshi Tokushima University|Integrative Medicine Japan KAKEN Search Researchers
Keywords
Hyperuricemia
Urate-Lowering Therapy
Selective Urate Reabsorption Inhibitor
Chronic Kidney Disease
Preventing Early Renal Loss in Diabetes
American College of Rheumatology
Content Type
Journal Article
Description
Hyperuricemia is a clinical important problem and its prevalence has been increased. Latest topics are described. The guideline adequately managing gout was published from American College of Rheumatology (ACR). Various optimal uses of urate-lowering therapy (ULT) were presented. The cardiorenal effects of hyperuricemia have been investigated for years. Regarding the patients on chronic kidney disease (CKD) and high risk of progression, ULT with allopurinol did not show the decline in eGFR compared to the control. Recently, dotinurad that is a new selective urate reabsorption inhibitor (SURI) would be applied to medical practice. Low-dose dotinurad showed satisfactory pharmacological efficacy.
Journal Title
Diabetes Research : Open Access
Publisher
Asploro
Volume
3
Issue
1
Start Page
16
End Page
19
Published Date
2021-04-27
Rights
This is an open-access article distributed under the Creative Commons Attribution License(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
DOI (Published Version)
URL ( Publisher's Version )
FullText File
language
eng
TextVersion
Publisher
departments
Medical Sciences